Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study von Subbiah, V., Kreitman, R.J., Wainberg, Z.A., Cho, J.Y., Schellens, J.H.M., Soria, J.C., Wen, P.Y., Zielinski, C.C., Cabanillas, M.E., Boran, A., Ilankumaran, P., Burgess, P., Romero Salas, T., Keam, B.

Volltext

Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotox von Kreitman, Robert J, Pastan, Ira

Volltext

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia von Kreitman, Robert J., Dearden, Claire, Zinzani, Pier Luigi, Delgado, Julio, Karlin, Lionel, Robak, Tadeusz, Gladstone, Douglas E., le Coutre, Philipp, Dietrich, Sascha, Gotic, Mirjana, Larratt, Loree, Offner, Fritz, Schiller, Gary, Swords, Ronan, Bacon, Larry, Bocchia, Monica, Bouabdallah, Krimo, Breems, Dimitri A., Cortelezzi, Agostino, Dinner, Shira, Doubek, Michael, Gjertsen, Bjorn Tore, Gobbi, Marco, Hellmann, Andrzej, Lepretre, Stephane, Maloisel, Frederic, Ravandi, Farhad, Rousselot, Philippe, Rummel, Mathias, Siddiqi, Tanya, Tadmor, Tamar, Troussard, Xavier, Yi, Cecilia Arana, Saglio, Giuseppe, Roboz, Gail J., Balic, Kemal, Standifer, Nathan, He, Peng, Marshall, Shannon, Wilson, Wyndham, Pastan, Ira, Yao, Nai-Shun, Giles, Francis

Volltext

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer von Subbiah, Vivek, Kreitman, Robert J, Wainberg, Zev A, Cho, Jae Yong, Schellens, Jan H M, Soria, Jean Charles, Wen, Patrick Y, Zielinski, Christoph, Cabanillas, Maria E, Urbanowitz, Gladys, Mookerjee, Bijoyesh, Wang, Dazhe, Rangwala, Fatima, Keam, Bhumsuk

Volltext

Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia von KREITMAN, Robert J, TALLMAN, Martin S, ROBAK, Tadeusz, COUTRE, Steven, WILSON, Wyndham H, STETLER-STEVENSON, Maryalice, FITZGERALD, David J, LECHLEIDER, Robert, PASTAN, Ira

Volltext

Immunotoxins for targeted cancer therapy von Kreitman, Robert J

Volltext

High prevalence of MAP2K1 mutations in variant and IGHV4-34–expressing hairy-cell leukemias von Waterfall, Joshua J, Arons, Evgeny, Walker, Robert L, Pineda, Marbin, Roth, Laura, Killian, J Keith, Abaan, Ogan D, Davis, Sean R, Kreitman, Robert J, Meltzer, Paul S

Volltext

Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P von KREITMAN, Robert J, HASSAN, Raffit, FITZGERALD, David J, PASTAN, Ira

Volltext

Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell Leukemia von Kreitman, Robert J., Pastan, Ira

Volltext

Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues von Kreitman, Robert J., Arons, Evgeny

Volltext

Attacked by Excrement: The Political Ecology of Shit in Wartime and Postwar Tokyo von Kreitman, Paul

Volltext

Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes von Liu, Wenhai, Onda, Masanori, Lee, Byungkook, Kreitman, Robert J, Hassan, Raffit, Xiang, Laiman, Pastan, Ira

Volltext

Immunotoxins for leukemia von Wayne, Alan S., FitzGerald, David J., Kreitman, Robert J., Pastan, Ira

Volltext

Immunotoxin treatment of cancer von Pastan, Ira, Hassan, Raffit, FitzGerald, David J, Kreitman, Robert J

Volltext

Functional biology in its natural context: A search for emergent simplicity von Bergelson, Joy, Kreitman, Martin, Petrov, Dmitri A, Sanchez, Alvaro, Tikhonov, Mikhail

Volltext

Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience von Chihara, Dai, Gras, Luuk, Zinger, Nienke, Kröger, Nicolaus, Mayer, Jiri, Passweg, Jakob, De Latour, Régis Peffault, Byrne, Jenny, Krüger, William, Bohn, Jan-Paul, Platzbecker, Uwe, Blau, Igor Wolfgang, Bonifazi, Francesca, Helbig, Grzegorz, McDonald, Andrew, Mistrik, Martin, Mohty, Mohamad, Ram, Ron, Sanz, Jaime, Llamas, Carlos Vallejo, Kreitman, Robert J, Hayden, Patrick J, McLornan, Donal, Tournilhac, Olivier, Van Gelder, Michel, Yakoub-Agha, Ibrahim

Volltext

Characterization of CD22 expression in acute lymphoblastic leukemia von Shah, Nirali N., Stevenson, Maryalice Stetler, Yuan, Constance M., Richards, Kelly, Delbrook, Cindy, Kreitman, Robert J., Pastan, Ira, Wayne, Alan S.

Volltext

Phase I Study of SS1P, a Recombinant Anti-Mesothelin Immunotoxin Given as a Bolus I.V. Infusion to Patients with Mesothelin-Expressing Mesothelioma, Ovarian, and Pancreatic Cancers von HASSAN, Raffit, BULLOCK, Susie, PREMKUMAR, Ahalya, KREITMAN, Robert J, KINDLER, Hedy, WILLINGHAM, Mark C, PASTAN, Ira

Volltext

Immunotoxins: From Design to Clinical Application von Kreitman, Robert J, Pastan, Ira

Volltext

Immunotoxin therapy of cancer von Pastan, Ira, Hassan, Raffit, FitzGerald, David J, Kreitman, Robert J

Volltext